The Scottish Office made sufficient funding available for recombinant Factor 8 for young or new patients, but in due course this was to extend to all patients. Linked evidence SCGV0000116_166 - Submission by I A Snedden NHS Management Executive - 03 Jun 1996 Chronology Information Date: 3 June 1996 Chapter/issue vCJD